SPHERA FUNDS MANAGEMENT LTD. 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-05 09:12 am Sale | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | SPHERA FUNDS MANAGEMENT LTD. | 1,562,907 2.530% | -533,351 (-25.44%) | Filing |
| 2023-03-07 06:01 am Purchase | 2023-03-03 | 13G | Inozyme Pharma, Inc. INZY | SPHERA FUNDS MANAGEMENT LTD. | 2,096,258 5.190% | 2,096,258 (New Position) | Filing |